- Home
- AIFF vs LTRN Comparison
AIFF vs LTRN Comparison
Compare AIFF & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFF
- LTRN
- Stock Information
- Founded
- AIFF 2006
- LTRN 2013
- Country
- AIFF United States
- LTRN United States
- Employees
- AIFF N/A
- LTRN N/A
- Industry
- AIFF
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- AIFF
- LTRN Health Care
- Exchange
- AIFF NYSE
- LTRN Nasdaq
- Market Cap
- AIFF 37.9M
- LTRN 36.0M
- IPO Year
- AIFF N/A
- LTRN 2020
- Fundamental
- Price
- AIFF $3.03
- LTRN $3.34
- Analyst Decision
- AIFF
- LTRN Strong Buy
- Analyst Count
- AIFF 0
- LTRN 1
- Target Price
- AIFF N/A
- LTRN $25.00
- AVG Volume (30 Days)
- AIFF 1.6M
- LTRN 51.0K
- Earning Date
- AIFF 08-18-2025
- LTRN 08-07-2025
- Dividend Yield
- AIFF N/A
- LTRN N/A
- EPS Growth
- AIFF N/A
- LTRN N/A
- EPS
- AIFF N/A
- LTRN N/A
- Revenue
- AIFF $139,000.00
- LTRN N/A
- Revenue This Year
- AIFF N/A
- LTRN N/A
- Revenue Next Year
- AIFF N/A
- LTRN N/A
- P/E Ratio
- AIFF N/A
- LTRN N/A
- Revenue Growth
- AIFF N/A
- LTRN N/A
- 52 Week Low
- AIFF $1.86
- LTRN $2.55
- 52 Week High
- AIFF $17.20
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- AIFF 55.14
- LTRN 50.68
- Support Level
- AIFF $2.70
- LTRN $3.09
- Resistance Level
- AIFF $3.09
- LTRN $3.31
- Average True Range (ATR)
- AIFF 0.25
- LTRN 0.16
- MACD
- AIFF 0.03
- LTRN 0.02
- Stochastic Oscillator
- AIFF 47.74
- LTRN 78.06
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.